ReviewWater science and technology : a journal of the International Association on Water Pollution Research2026
Removal of organic micropollutants in granular activated carbon filters - review of long-term and full-scale experiences from municipal wastewater treatment.
Review in Water science and technology : a journal of the International Association on Water Pollution Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Granular activated carbon (GAC) filtration is increasingly used for quaternary treatment of municipal wastewater to remove organic micropollutants, in line with the revised EU Urban Wastewater Treatment Directive (Directive (EU) 2024/3019). This review compiles and synthesises available, peer-reviewed, and long-term pilot- and full-scale studies and, in contrast to previous reviews, particularly addresses breakthrough of Urban Wastewater Treatment Directive (UWWTD) relevant indicator compounds in relation to operational lifespan and regulatory compliance. Most studies were conducted at pilot scale, with considerable variation in empty bed contact time, filtration rate, and GAC type. Breakthrough of indicator compounds varied widely, but citalopram, metoprolol, benzotriazole, and methylbenzotriazole generally showed relatively late breakthrough, indicating potential for longer filter lifespan, whereas candesartan and irbesartan more often showed early breakthrough. The available data further indicate that the selection of indicator compounds strongly affects the operational lifespan over which compliance with the UWWTD may be maintained. However, the limited number of long-term full-scale studies and the large variability in pre-treatment, filter design, carbon type, and operating conditions prevent robust quantitative assessment of these relationships. The findings highlight the need for more large-scale, long-term studies using a systematic evaluation framework to support the effective implementation of GAC filtration for UWWTD compliance.
Indexed as
Identifiers
42460561What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.